CIRM has teamed up the International Alliance for Biological Standardization (IABS) to present the 4th Cell Therapy Conference Manufacturing and Testing of Pluripotent Stem Cells. The conference, June 5-6, 2018 in Los Angeles, is a must attend event for clinical and pre-clinical pluripotent stem cell product development teams. Several development programs in the pluripotent stem cell space will be described. The meeting will also address unresolved issues related to the manufacture and testing of pluripotent stem cell-based therapies. The overall goal is to provide participants with a strategic roadmap, so their new treatments are well positioned to achieve the highest regulatory standards and be made available to patients around the world.
Leading opinion leaders in cell therapy development from industry, government, and academia plus regulatory authorities from the FDA, European Medicines Agency, Japan Pharmaceuticals and Medical Devices Agency, and World Health Organization will attend. In addition to the conference program, there will extensive opportunities for one-to-one discussion and networking.
For more information please visit the IABS conference website.
To view the conference agenda click here.
To book a hotel room at the discount rate click here.